Teija Parpala is a prominent inventor based in Oulu, Finland. She has made significant contributions to the field of pharmaceutical delivery, holding a total of 3 patents. Her innovative work focuses on methods and devices that enhance the delivery of pharmaceuticals to target tissues.

Latest Patents

One of her latest patents is titled "Perfusion apparatus and methods for pharmaceutical delivery." This invention provides methods and devices for delivering pharmaceuticals to target tissues in various settings, including in situ, in vivo, ex vivo, or in vitro. The technology involves contacting target tissues with pharmaceuticals in a re-circulating, oxygenated perfusate solution, ensuring effective delivery. Another notable patent is the "Method for viral vector delivery." This method facilitates the effective delivery of viral vector gene therapy pharmaceuticals using a similar re-circulating, oxygenated perfusate solution, maintained at approximately 37°C for optimal results.

Career Highlights

Teija has worked with various companies throughout her career, including Biostratum Incorporation. Her expertise in pharmaceutical delivery systems has positioned her as a key figure in the industry.

Collaborations

Teija has collaborated with notable professionals in her field, including Karl Kristian Tryggvason and Olavi Lukkarinen. These collaborations have further enriched her research and development efforts.

Conclusion

Teija Parpala's innovative contributions to pharmaceutical delivery technologies demonstrate her commitment to advancing medical science. Her patents reflect her dedication to improving therapeutic outcomes through effective delivery methods.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com